CannaPharmaRx to Host Investor Conference Call
CannaPharmaRx (OTC PINK:CPMD) announced an upcoming investor conference call on May 21, 2024, at 1 PM EST, led by CEO Dean Medwid. The call will cover a review of financials and achievements, product and harvesting updates, purchase orders, inventory and shipments, distributor and expansion updates, and forecasted revenues. Interested parties can join by dialing 530-881-1212 with ID Pin 615-253-385# and Passcode 1674609. A recording will be available upon request.
- Scheduled investor conference call shows transparency and proactive communication.
- Topics to be covered include financial achievements and forecasted revenues, indicating potential positive performance.
- Updates on product and harvesting show operational progress.
- Discussing distributor and expansion updates suggests growth strategy.
- No specific financial data or performance indicators presented in the PR.
- Potential dilution of shareholder value if expansion requires additional funding.
- Lack of detail on shipment volumes or revenue figures raises questions about actual business performance.
CALGARY, AB / ACCESSWIRE / May 20, 2024 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it will hold an investor conference call on Wednesday, May 21, 2024, at 1PM Eastern time to give an update on progress.
Chief Executive Officer Dean Medwid will be leading the discussion on various topics including:
- Review of financials and achievements
- Product and harvesting update
- Update on purchase orders, inventory and shipments
- Distributor and expansion update
- Forecasted Revenues
Interested parties can join the conference call by dialing in: When: Tuesday, 05/21/24 at 1:00 pm EST Phone Number: 530-881-1212 ID Pin: 615-253-385# | Passcode: 1674609 |
For interested individuals unable to join the conference call a recording will be available upon request.
Please visit www.cannapharmarx.com for additional information about our company and products.
About CannapharmaRx, Inc.
CannapharmaRx is focused on the acquisition and development of state-of-the-art cannabis grow facilities in Canada. CPMD is in discussion with other companies regarding potential acquisitions. CannapharmaRx's business strategy is to become a leader in high quality and low-cost production of cannabis through the development, acquisition, and enhancement of existing facilities. CannapharmaRx is committed to operating high-quality facilities utilizing the latest technology in combined heat and power generation to ensure being a low-cost producer of cannabis.
Safe Harbor Statement
Cautionary Note Regarding Forward-Looking Information or Statements
This press release contains forward-looking information or statements. All statements that are or information which is not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations, or beliefs of future performance, are 'forward-looking information or statements.' Forward-looking information or statements can be identified by the use of words such as 'plans,' 'expects,' or 'does not expect,' 'is expected,' 'estimates,' 'intends,' 'anticipates,' or 'does not anticipate,' or 'believes,' or variations of such words and phrases or statements that certain actions, events or results 'may,' 'could,' 'would,' 'might' or 'will' be taken, occur or be achieved. With respect to forward-looking information and statements contained herein, Management of CannapharmaRx has made numerous assumptions, including, among other things, assumptions about general business and economic conditions. Such forward-looking statements are based on assumptions and involve known and unknown risks, uncertainties, and other factors that may cause actual results, events, or developments to be materially different from any future results, events, or developments expressed or implied by such forward-looking information or statements. Readers are cautioned not to place undue reliance on such forward-looking information or statements. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking information or statements. CannapharmaRx assumes no obligation to update any forward-looking information or statements, even if new information becomes available as a result of future events, new information, or for any other reason except as required by law.
Contact Information:
Brokers and Analysts
Chesapeake Group
(410) 825-3930
SOURCE: CannaPharmaRx
View the original press release on accesswire.com
FAQ
When is the CannaPharmaRx investor conference call?
What topics will be covered in the CannaPharmaRx conference call on May 21, 2024?
How can I join the CannaPharmaRx investor conference call?
Who will lead the CannaPharmaRx investor conference call?
Will a recording of the CannaPharmaRx investor conference call be available?
